184 related articles for article (PubMed ID: 18622063)
1. Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats.
Iqbal M; Dubey K; Anwer T; Ashish A; Pillai KK
Pharmacol Rep; 2008; 60(3):382-90. PubMed ID: 18622063
[TBL] [Abstract][Full Text] [Related]
2. Myocardial salvaging effect of telmisartan in experimental model of myocardial infarction.
Goyal S; Arora S; Mittal R; Joshi S; Nag TC; Ray R; Kumari S; Arya DS
Eur J Pharmacol; 2009 Oct; 619(1-3):75-84. PubMed ID: 19664617
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity.
Ibrahim MA; Ashour OM; Ibrahim YF; El-Bitar HI; Gomaa W; Abdel-Rahim SR
Pharmacol Res; 2009 Nov; 60(5):373-81. PubMed ID: 19467331
[TBL] [Abstract][Full Text] [Related]
4. Effect of telmisartan in limiting the cardiotoxic effect of daunorubicin in rats.
Arozal W; Watanabe K; Veeraveedu PT; Thandavarayan RA; Harima M; Sukumaran V; Suzuki K; Kodama M; Aizawa Y
J Pharm Pharmacol; 2010 Dec; 62(12):1776-83. PubMed ID: 21054405
[TBL] [Abstract][Full Text] [Related]
5. Vitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response.
Hadi N; Yousif NG; Al-amran FG; Huntei NK; Mohammad BI; Ali SJ
BMC Cardiovasc Disord; 2012 Aug; 12():63. PubMed ID: 22867422
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats.
Fadillioğlu E; Erdoğan H; Söğüt S; Kuku I
J Appl Toxicol; 2003; 23(1):71-4. PubMed ID: 12518339
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of aliskiren in doxorubicin-induced acute cardiomyopathy in rats.
Rashikh A; Abul Kalam Najmi ; Akhtar M; Mahmood D; Pillai KK; Ahmad SJ
Hum Exp Toxicol; 2011 Feb; 30(2):102-9. PubMed ID: 20418268
[TBL] [Abstract][Full Text] [Related]
8. Quercetin augments the protective effect of losartan against chronic doxorubicin cardiotoxicity in rats.
Matouk AI; Taye A; Heeba GH; El-Moselhy MA
Environ Toxicol Pharmacol; 2013 Sep; 36(2):443-450. PubMed ID: 23770454
[TBL] [Abstract][Full Text] [Related]
9. Regulation of angiotensin-(1-7) and angiotensin II type 1 receptor by telmisartan and losartan in adriamycin-induced rat heart failure.
Zong WN; Yang XH; Chen XM; Huang HJ; Zheng HJ; Qin XY; Yong YH; Cao K; Huang J; Lu XZ
Acta Pharmacol Sin; 2011 Nov; 32(11):1345-50. PubMed ID: 21963897
[TBL] [Abstract][Full Text] [Related]
10. Modulation of PPAR-gamma by telmisartan protects the heart against myocardial infarction in experimental diabetes.
Goyal S; Arora S; Bhatt TK; Das P; Sharma A; Kumari S; Arya DS
Chem Biol Interact; 2010 May; 185(3):271-80. PubMed ID: 20307515
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of a direct renin inhibitor in acute murine model of cardiotoxicity and nephrotoxicity.
Rashikh A; Pillai KK; Najmi AK
Fundam Clin Pharmacol; 2014 Oct; 28(5):489-500. PubMed ID: 24117488
[TBL] [Abstract][Full Text] [Related]
12. Chemo protective activity of carotenoid meso-zeaxanthin against doxorubicin-induced cardio toxicity.
Firdous AP; Kuttan R
J Exp Ther Oncol; 2012; 10(2):101-6. PubMed ID: 23350349
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of telmisartan against oxidative damage induced by high glucose in neuronal PC12 cell.
Eslami H; Sharifi AM; Rahimi H; Rahati M
Neurosci Lett; 2014 Jan; 558():31-6. PubMed ID: 24211690
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes.
Goyal SN; Bharti S; Bhatia J; Nag TC; Ray R; Arya DS
Diabetes Obes Metab; 2011 Jun; 13(6):533-41. PubMed ID: 21320264
[TBL] [Abstract][Full Text] [Related]
15. Telmisartan treatment attenuates arsenic-induced hepatotoxicity in mice.
Fouad AA; Al-Mulhim AS; Jresat I
Toxicology; 2012 Oct; 300(3):149-57. PubMed ID: 22750630
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of curcumin nanoparticles against cardiotoxicity induced by doxorubicin in rat.
Mohammed HS; Hosny EN; Khadrawy YA; Magdy M; Attia YS; Sayed OA; AbdElaal M
Biochim Biophys Acta Mol Basis Dis; 2020 May; 1866(5):165665. PubMed ID: 31918005
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats.
Tawfik MK
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):600-9. PubMed ID: 22774400
[TBL] [Abstract][Full Text] [Related]
18. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
Saad SY; Najjar TA; Alashari M
J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic role of telmisartan against acetaminophen hepatotoxicity in mice.
Fouad AA; Al-Mulhim AS; Jresat I; Gomaa W
Eur J Pharmacol; 2012 Oct; 693(1-3):64-71. PubMed ID: 22940262
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of caffeic acid phenethyl ester on doxorubicin-induced cardiotoxicity in rats.
Fadillioglu E; Oztas E; Erdogan H; Yagmurca M; Sogut S; Ucar M; Irmak MK
J Appl Toxicol; 2004; 24(1):47-52. PubMed ID: 14745846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
